Location: Home
  • search
  • go
  • Relate News
  • 11/13/2017The National Cancer Center Joins Hands with WHO on the Fight against C...
  • 11/13/2017XiAn Janssen Launches IMBRUVICA (ibrutinib) in China
  • 11/13/2017CFDA Issues New Announcement to Adjust Drug Registration Acceptance Ru...
  • 11/13/2017CDE Seeks Comments on First List of Essential Drugs Eligible for BE Ex...
  • 11/13/2017Pfizer Divests from Chinese JV with Hisun
  • 11/10/2017Time for MNCs to Stay Sober as China Unleashes Enticing Drug Regulator...
  • 11/9/2017AstraZeneca Bets on Continued Growth in China as GSK Fades
  • 11/9/2017Recent Executive Moves
  • 11/9/2017SMEI: Chinese Drug Sales Growth Expected to Fall Further in 2017
  • 11/8/2017BeiGene Completes Construction of Its Manufacturing Facility in Suzhou
  • 11/8/2017Tsumura to Penetrate China's Herbal Drug Market with the Help of Ping ...
  • 11/8/2017Biotest and Tiancheng Pharma to Rework Their Acquisition Deal after Na...
  • 11/8/2017Cipla to Re-enter China Market Soon with Focus on Respiratory System D...
  • 11/8/2017CFDA Suspends Import of Rabeprazole API from India for Chinese GMP Iss...
  • 11/8/2017CBMG Opens New Facility and Joint Lab for Cell Therapy in Shanghai
  • 11/8/2017Xynomic Licenses Global Rights of RAF Inhibitor from Boehringer Ingelh...
  • 11/8/2017Chugai Completes Phase III Study of Osteoporosis Drug with Planning 20...
  • 11/7/2017FDA Warns Chinese Firm for Multiple Failures of Its OTC Drug
  • 11/7/2017EddingPharm Spinoff Strives to Bring Potential Oncology Blockbusters t...
  • 11/7/2017Pfizer Builds World's First LEED Platinum Pharma Facility in Dalian
  • 11/7/2017CFDA Finds 650,000 Faulty Infant Vaccines
  • 11/7/2017Precision Medicinie Start-up AnchorDx Raises $28M in Series B Round
  • 11/7/2017China to Restrict Production of API Producers in 28 Cities This Winter
  • 11/6/2017China Stiffens Penalty on Parties Offering Bribes with Amended Anti-Un...
  • 11/6/2017CFDA Accepts BMS's NDA for Optivo (Nivolumab)
  • 11/6/2017SIMM Granted Clinical Trial Approval for New Alzheimer's Drug
  • 11/6/2017Eisai Submits Chinese NDA for Hepatic Cancer Drug Lenvima
  • 11/3/2017Fosun to Acquire the Ramaining 69.25% Stake in Taiwan-Based Henlix Bio...
  • 11/3/2017Sinotau, HTA to Co-market A New β-amyloid Imaging Agent in China
  • 11/3/2017iPharma Licenses Worldwide Rights of Boehringer Ingelheim's FAKi BI 85...
  • Page:290/720 Total number of articles:21580: [First][<<] [288] [289] [290] [291] [292] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group